发明名称 COMBINATION THERAPY FOR TREATMENT OF OBESITY AND DIABETES AND CONDITION RELATED THERETO AND FOR TREATMENT OF CONDITION AMELIORATED BY INCREASING BLOOD GLP-1 LEVEL
摘要 <P>PROBLEM TO BE SOLVED: To provide a composition for treating or preventing diabetes or a condition related thereto comprising a therapeutically effective amount of a BRS-3 agonist and a DPP-IV inhibitor. <P>SOLUTION: The invention concerns combination of an amount of a BRS-3 agonist with an amount of a dipeptidyl peptidase IV (DPP-IV) inhibitor such that the combination provides an effect in lowering a blood glucose level or in increasing a blood GLP-1 level in a subject over that provided by the amount of the BRS-3 agonist alone and by the amount of the DPP-IV inhibitor alone and the use of such a combination for treating or preventing obesity and diabetes and conditions related thereto and conditions ameliorated by increasing a blood GLP-1 level. The invention also relates to the use of a G protein-coupled receptor to screen for GLP-1 secretagogues. <P>COPYRIGHT: (C)2012,JPO&INPIT
申请公布号 JP2012136554(A) 申请公布日期 2012.07.19
申请号 JP20120090364 申请日期 2012.04.11
申请人 ARENA PHARMACEUTICALS INC 发明人 CHU ZHI-LIANG;LEONARD JAMES N
分类号 A61K45/06;A61P3/00;A61P3/04;A61P3/06;A61P3/10;A61P5/48;A61P5/50;A61P9/00;A61P9/10;A61P9/12;A61P13/12;A61P21/00;A61P25/00;A61P25/02;A61P25/08;A61P25/14;A61P25/16;A61P25/28;A61P27/02;A61P27/12;A61P43/00;C12N15/09 主分类号 A61K45/06
代理机构 代理人
主权项
地址